Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Postgraduate Medicine|September 16, 2015
User's guide to mechanism of action and clinical use of GLP-1 receptor agonistsCharles F Shaefer, Pamela Kushner, Richard AguilarClinical Therapeutics|September 26, 2017
HbA1c Outcomes in Patients Treated With Canagliflozin Versus Sitagliptin in US Health PlansSarah Thayer, Richard Aguilar, Stephanie Korrer, et al.Current Medical Research and Opinion|March 4, 2016
Real-world evaluation of glycemic control among patients with type 2 diabetes mellitus treated with canagliflozin versus dipeptidyl peptidase-4 inhibitorsSarah Thayer, Wing Chow, Stephanie Korrer, et al.Clinical Therapeutics|September 20, 2014
Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trialsRosemarie Lajara, Richard Aguilar, Uwe Hehnke, et al.Current Medical Research and Opinion|September 29, 2015
Canagliflozin treatment of Hispanic and non-Hispanic patients with type 2 diabetes in a US managed care settingWing Chow, Erin Buysman, Marcia F T Rupnow, et al.Ethnicity & Disease|April 23, 2016
Efficacy and Safety of Canagliflozin in Type 2 Diabetes Patients of Different EthnicityJaime A Davidson, Richard Aguilar, Fernando J Lavalle González, et al.Pageof 1